68 related articles for article (PubMed ID: 19368038)
1. Understanding Stimulant Use and Use Disorders in a New Era.
Ciccarone D; Shoptaw S
Med Clin North Am; 2022 Jan; 106(1):81-97. PubMed ID: 34823736
[TBL] [Abstract][Full Text] [Related]
2. Circumspectives: The Replacements.
Heilig M; Carlezon WA
Neuropsychopharmacology; 2015 Jul; 40(8):1813-4. PubMed ID: 26068571
[No Abstract] [Full Text] [Related]
3. Vascular disease in cocaine addiction.
Bachi K; Mani V; Jeyachandran D; Fayad ZA; Goldstein RZ; Alia-Klein N
Atherosclerosis; 2017 Jul; 262():154-162. PubMed ID: 28363516
[TBL] [Abstract][Full Text] [Related]
4. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.
; ; ;
J Addict Med; 2024 May-Jun 01; 18(1S Suppl 1):1-56. PubMed ID: 38669101
[TBL] [Abstract][Full Text] [Related]
5. If there were an effective pharmacotherapy for cocaine use disorder, what would it do?
Shoptaw S; Trivedi M; Potter JS
Addiction; 2021 Apr; 116(4):714-715. PubMed ID: 33269478
[TBL] [Abstract][Full Text] [Related]
6. Next-generation vaccines for substance use disorders.
Wang K; Wang H; Wang X
Zool Res; 2024 May; 45(3):707-708. PubMed ID: 38766752
[No Abstract] [Full Text] [Related]
7. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
Vocci FJ; Montoya ID
Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
[TBL] [Abstract][Full Text] [Related]
8. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.
Regier PS; Kampman KM; Childress AR
Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666
[TBL] [Abstract][Full Text] [Related]
9. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
Rothman RB; Blough BE; Baumann MH
Exp Clin Psychopharmacol; 2008 Dec; 16(6):458-74. PubMed ID: 19086767
[TBL] [Abstract][Full Text] [Related]
10. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
Ciccarone D
Prim Care; 2011 Mar; 38(1):41-58. PubMed ID: 21356420
[TBL] [Abstract][Full Text] [Related]
11. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
Dwoskin LP
Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
[No Abstract] [Full Text] [Related]
12. Overcoming cocaine or stimulant addiction. Medications offer modest help; vaccines are in development.
Harv Ment Health Lett; 2009 Mar; 25(9):6-7. PubMed ID: 19368038
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
